Latest news
Loading news…
Oruka Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Waltham, Massachusetts, United States Founded 2024 101-250 employees For Profit
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Ticker
ORKA
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ORKA
- Exchange
- NASDAQ
- IPO date
- Sep 3, 2024
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 16
- IT spend
- $128.44K
Company Info
- Founded
- 2024
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 78
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Sep 3, 2024
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -4
- Trend (90d)
- -0.4
- Last leadership hire
- Dec 11, 2025
Acquisitions by Oruka Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Oruka Therapeutics
Loading news…
FAQs about Oruka Therapeutics
People who checked this page also checked these
Sectors Oruka Therapeutics invests & acquires in
Browse the full Acquirezy directory.